ResMed | Des Atouts



Assets Changement Date
Ansell USD 3.24B 717.4M 2024-06
AtriCure USD 608.85M 17.22M 2025-06
Baxter International USD 21.3B 4.48B 2025-03
Cochlear AUD 2.79B 41M 2024-12
Cooper Companies USD 12.41B 191.4M 2025-04
CSL USD 38.45B 425M 2024-12
Dexcom USD 7.33B 575.3M 2025-06
Edwards Lifesciences USD 13.02B 33M 2025-03
Fisher Paykel Healthcare NZD 2.44B 153.7M 2024-09
Globus Medical USD 4.96B 249.94M 2025-06
Haemonetics USD 2.46B 11.15M 2025-06
Hologic USD 8.81B 261M 2025-06
Idexx Laboratories USD 3.33B 117.1M 2025-06
Insulet USD 3.47B 48.1M 2025-06
Integra LifeSciences USD 3.67B 384.85M 2025-06
Intuitive Surgical USD 20.16B 942.8M 2025-06
Masimo USD 2.4B 109.5M 2025-06
Medtronic USD 91.68B 1.71B 2025-04
Philips EUR 26.38B 788M 2025-06
Ramsay Health Care AUD 20.66B 237M 2024-12
ResMed USD 8.17B 607.57M 2025-06
Sigma Healthcare AUD 1.7B 324.84M 2024-07
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Steris USD 10.4B 258.19M 2025-06
Teleflex USD 7.38B 211.93M 2025-06
Thermo Fisher Scientific USD 101.23B 2.19B 2025-06


ResMed Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.